Concepedia

Mark A. Young

MA

44

Publications

2.2K

Citations

24

H-Index

1982

Active since

Affiliations

Intercept Pharmaceuticals (United States)(Current)

La Trobe University

Harvard University

Johns Hopkins University

VA Palo Alto Health Care System

Mark A. Young is an author at Intercept Pharmaceuticals (United States) specializing in medicine, cardiovascular disease, and cardiology.

ORCID

Top concepts

Publications per year

1982–2022

44

Publications

44

Eccentric decline squat protocol offers superior results at 12 months compared with traditional eccentric protocol for patellar tendinopathy in volleyball players

Mark A. Young, J L Cook, Craig Purdam et al. · British Journal of Sports Medicine · 2005 · 315 citations · Full text

Obesity and pronated foot type may increase the risk of chronic plantar heel pain: a matched case-control study

Damien Irving, Jill Cook, Mark A. Young et al. · BMC Musculoskeletal Disorders · 2007 · 254 citations · Full text

Impact of Chronic Plantar Heel Pain on Health-Related Quality of Life

Damien Irving, Jill Cook, Mark A. Young et al. · Journal of the American Podiatric Medical Association · 2008 · 231 citations

Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure

Vincenzo Lionetti, Axel Linke, Mary H.H. Chandler et al. · Cardiovascular Research · 2005 · 119 citations · Full text

MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice

John D. Belcher, Mark A. Young, Chunsheng Chen et al. · Blood · 2013 · 86 citations · Full text

Rows per page

1–5 of 44